Table 6.
Parameter | PE in MR | UC | MW | SW | SV | SR | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
Z | p | Z | p | Z | p | Z | p | Z | p | ||
βPIR → IL1 | 0.74 | Id | |||||||||
βPIR → IL6 | 0.69 *** | −0.40 | |||||||||
βPIR → MMP8 | 0.67 *** | −0.24 | 0.813 | ||||||||
βBDI → CAL | −0.03 ns | 2.17 | 0.030 | 2.17 | 0.030 | ||||||
βBDI → OHIP | 0.11 ns | −0.53 | 0.595 | −0.53 | 0.595 | ||||||
ΒCAL → AIP | 0.67 * | −1.05 | 0.296 | −1.43 | 0.154 | ||||||
ΒCAL → OHIP | 0.27 * | −0.19 | 0.849 | −0.19 | 0.849 | ||||||
σ2BDI | 46.57 *** | 2.68 | 0.007 | 2.68 | 0.007 | 2.68 | 0.007 | ||||
σ2ε_IL-1β | 0.65 *** | −1.75 | 0.081 | −1.71 | 0.087 | −1.81 | 0.070 | −1.81 | 0.070 | ||
σ2ε_IL-6 | 0.26 *** | −0.61 | 0.543 | −0.80 | 0.427 | −0.67 | 0.504 | −0.67 | 0.504 | ||
σ2ε_MMP-8 | 0.47 *** | −1.18 | 0.238 | −1.31 | 0.189 | −1.22 | 0.223 | −1.22 | 0.223 | ||
σ2ε_CAL | 0.13 *** | 1.07 | 0.284 | 1.07 | 0.284 | 0.98 | 0.325 | 0.98 | 0.325 | −1.36 | 0.174 |
σ2ε_OHIP | 118.04 *** | 0.60 | 0.551 | 0.60 | 0.551 | 0.59 | 0.558 | 0.59 | 0.558 | −1.97 | 0.049 |
σ2ε_PIR | 0.43 * | −0.43 | 0.671 | −0.74 | 0.457 | −0.86 | 0.391 | −0.86 | 0.391 | −0.84 | 0.399 |
Note. Parameter: β = measurement or structural weight, σ2 = structural variance, and σ2ε = error variance. Id = Parameter identified or set to 1 in both samples = βPIR → IL1β. Statistic: PE in MR = point estimation in the nested model with constraints on measurement residuals (statistical significance of the parameter at a two-tailed test: ns = non-significance p > 0.05, * p ≤ 0.05, p ≤ 0.01, *** p ≤ 0.001), Z = Z-test statistic, p = probability value at a two-tailed test. Nested models: UC = unconstrained model, MW = model with constraints on the measurement weights, SW = model with constraints on the structural weights, SC = model with constrains on the structural covariances, and SR = model with constrains on the structural residuals. Variables: PIR = proinflammatory immune response, BDI = total score in the Beck Depression Inventory-II, CAL = clinical attachment loss = mean of sites with insertion loss (≥1 mm) in each participant, IL-1β = Napierian logarithm of salivary interleukin 1 beta concentration, IL-6 = Napierian logarithm of salivary interleukin 6 beta concentration, and MMP-8 = Napierian logarithm of salivary matrix metalloproteinase-8 concentration.